Source: http://health.yahoo.net/news/s/nm/doubt-over-sanofi-drug-in-eu-may-hurt-wider-ms-market
Monday, 25 March 2013
Doubt over Sanofi drug in EU may hurt wider MS market
LONDON (Reuters) - Uncertainty over European exclusivity for Sanofi's new multiple sclerosis (MS) pill Aubagio could disrupt the wider market and impact other companies, according to a leading industry analyst. The French drugmaker won an appr...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.